Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant

Galena SalemDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Amy S. RuppertDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Patrick ElderDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Craig C. HofmeisterDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Don M. BensonDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Sam PenzaDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Leslie AndritsosDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Rebecca KlisovicDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Sumithira VasuDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

William BlumDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Steven M. DevineDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Samantha JaglowskiDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Yvonne A. EfeberaDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USACorrespondence[email protected]

Your download is now in progress and you may close this window